NCCN Educational Events & Resources
Treatment of hematologic malignancies is increasingly complex.
Issues relating to pathology, transplantation, and various
new therapies require hematologists and oncologists to stay
abreast of breakthrough advances. In addition, targeted
therapies and oral treatments bring the latest benefits to
patients. This congress focuses on new approaches that
have been incorporated into patient management, including
the use of drugs, biologics, and diagnostics. At the NCCN
Annual Congress on September 14 – 15, 2012, agenda
topics included acute lymphoblastic leukemia, chronic
myelogenous leukemia, lymphomas, multiple myeloma,
myelodysplastic syndromes, transplantation, and supportive
care topics, including management of anemia, management of
idiopathic thrombocytopenic purpura, and treatment of venous
thromboembolic disease. In 2012, the NCCN Annual Congress
had more than 587 registrants.
Annual Conference: Clinical Practice
Guidelines & Quality Cancer Care™
The NCCN Annual Conference attracts
registrants from across
the United States and the globe, including oncologists (in both
community and academic settings), oncology fellows, nurses,
pharmacists, and other health care professionals involved
in the care of patients with cancer. Respected opinion leaders
present the latest cancer therapies and provide updates on
selected NCCN Guidelines, the data upon which the NCCN
Guidelines are based, and quality initiatives in oncology.
Topics change annually but continue to focus on the major
cancers and supportive care areas. The NCCN Annual
Conference also includes case study discussion forums
with experts from NCCN Member Institutions and roundtable
discussions featuring the foremost professionals from the
academic, patient advocacy, government, payer, industry,
and business realms of cancer care.
The NCCN 17
Annual Conference: Clinical Practice Guidelines
& Quality Cancer Care™, including three pre-conference
programs for fellows, nurses, and pharmacists, was held
March 14 – 18, 2012. Roundtable discussions included
and Corporate America: Business as Usual?
for Patients: Who Decides?
, while NCCN Guidelines Update
Sessions focused on clinical practice decisions – bringing data
and practice together. Recorded webcasts of select sessions
were also made available to online learners through the NCCN
Continuing Education Portal at education.nccn.org.
Nearly 1,600 oncologists, oncology fellows, nurses, pharmacists,
and others involved in the treatment of people with cancer registered
for the NCCN 17